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Abstract
Background and Objective: Nonsyndromic cleft lip and/or palate (NSCL/P) is a complex disease associated with 
both genetic and environmental factors. One strategy for identifying of possible NSCL/P genetic causes is to 
evaluate polymorphic variants in genes involved in the craniofacial development.
Design: We carried out a case-control analysis of 13 single nucleotide polymorphisms in 9 genes related to cran-
iofacial development, including TBX1, PVRL1, MID1, RUNX2, TP63, TGFβ3, MSX1, MYH9 and JAG2, in 367 
patients with NSCL/P and 413 unaffected controls from Brazil to determine their association with NSCL/P.
Results: Four out of 13 polymorphisms (rs28649236 and rs4819522 of TBX1, rs7940667 of PVRL1 and rs1057744 
of JAG2) were presented in our population. Comparisons of allele and genotype frequencies revealed that the G 
variant allele and the AG/GG genotypes of TBX1 rs28649236 occurred in a frequency significantly higher in con-
trols than in the NSCL/P group (OR: 0.41; 95% CI: 0.25-0.67; p=0.0002). The frequencies of rs4819522, rs7940667 
and rs1057744 minor alleles and genotypes were similar between control and NSCL/P group, without significant 
differences. No significant associations among cleft types and polymorphisms were observed.
Conclusion: The study suggests for the first time evidences to an association of the G allele of TBX1 rs28649236 
polymorphism and NSCL/P.
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Introduction
Cleft lip and/or palate (CL/P) is the most common congen-
ital anomaly of the face, and its etiology, which involves 
both genetic and environmental factors, is highly com-
plex and the molecular basis remains largely unknown 
(1,2). CL/P is frequently an isolated disorder, named non-
syndromic (NSCL/P, MIM 119530), but in some cases it 
is associated with other alterations characterizing a syn-
drome (2). It has been reported more than 300 syndromes 
with CL/P as a common feature (1,2). NSCL/P has a wide 
geographical distribution, with an average birth preva-
lence of approximately 1:700 (1). One strategy that has 
helped in the identification of genetic risks of NSCL/P 
is the evaluation of single nucleotide polymorphisms in 
genes responsible for craniofacial development.
In this study we investigated the contribution of selected 
polymorphic variants in genes related to craniofacial de-
velopment as risk factors of NSCL/P. We selected the fol-
lowing genes: TP63, which is expressed in the epithelial 
cells during lip and palate formation and mutations are 
related to ectrodactyly, ectodermal dysplasia and cleft 
lip/palate syndrome (MIM 604292) (3), MID1 that is 
responsible for Opitz/GBBB syndrome (MIM 300000), 
a congenital disorder affecting primarily midline struc-
tures such as lip and palate (4), PVRL1 that encodes a 
cell-to-cell adhesion molecule (nectin1) expressed in the 
palatal shaves and related to cleft lip/palate-ectodermal 
dysplasia (MIM 225060) (5), RUNX2, which is largely 
expressed in the osteogenic mesenchyme during palate 
development (6) and that is responsible for cleidocranial 
dysplasia (MIM 119600), TBX1 that regulates cell ad-
hesion and palatal development and is associated with 
22q11.2 deletion syndrome (MIM 611867) (7), TGFβ3, 
which shows pleiotropic biological effects and is known 
to induce palatal fusion (8), MSX1 that, based on mouse 
expression studies and knockout model, is considered a 
candidate for orofacial clefting and gene dosage in hu-
mans increases the risk for both orofacial clefting and 
oligodontia (9), MYH9, which has its encoded product 
abundantly and specifically expressed in epithelial cells 
of palatal shelves before fusion (10), and JAG2 that en-
codes a cell surface protein essential for palate develop-
ment to prevent premature palatal shelf adhesion to other 
oral tissues and to facilitate normal adhesion between 
the elevated palatal shelves (11). Except for the poly-
morphisms rs7940667 in PVRL1 gene and rs1057744 in 
JAG2 gene, which have yielded inconsistent results (12-
15) there are no previous studies evaluating the selected 
polymorphisms in NSCL/P patients.
Material and Methods
-Samples
This study included 367 unrelated patients with NSCL/P 
recruited from the Center for Rehabilitation of Cranio-
facial Anomalies, Dental School, University of Alfenas, 
Brazil. All patients were carefully examined and screened 
for the presence of associated anomalies or syndromes by 
the team of the Center for Rehabilitation of Craniofacial 
Anomalies. The clefts were classified with the incisive 
foramen as reference, and divided in 3 groups: cleft lip 
only (CLO), cleft lip and palate (CLP), and cleft palate 
only (CPO). Controls were chosen among subjects ad-
mitted as in-patients in the Dental School of the same 
University with conditions unrelated to clefting disorders 
(n=413). The control group was matched by age, place of 
birth and ancestrality. In a recent study we characterized 
the ancestrality of those samples by using a panel of 40 
insertion-deletion markers (16). The average ancestry of 
the NSCL/P sample was estimated at 84.1% of Europe-
an, 13.4% of African and 2.5% of Amerindian, whereas 
ancestrality of control samples was 89.0% of European, 
8.1% of African and 2.9% of Amerindian for controls. 
Written informed consents were obtained from all partic-
ipants, and the study was carried out with approval of the 
Human Research Ethics Committee of the University.
-Genotyping
Genomic DNA was extracted from oral mucosa cells 
as previously described (17). Criteria for the selection 
of polymorphisms were as follows: (a) located within 
the region of an exon, (b) classified as non-synonymous 
polymorphism, (c) positioned in a restriction site, and (d) 
located in a conserved region of the gene in which alter-
ations could result in biological effects. Thirteen non-
synonymous polymorphic sites in TP63 (rs34713855), 
PVRL1 (rs7940667), MID1 (rs55986608), RUNX2 
(rs11498200), TBX1 (rs28649236, rs28939675 and 
rs4819522), TGFβ3 (rs34019007 and rs4252315), MYH9 
(rs11549909 and rs11549910), MSX1 (rs62636562) and 
JAG2 (rs1057744) were examined by polymerase chain 
reaction-restriction fragment length polymorphism 
(PCR-RFLP) analysis. Primers, restriction enzymes 
and PCR-RFLP conditions are available on request. Af-
ter incubation with restriction enzymes, the products 
were electrophoresed on 8% nondenaturing polyacry-
lamide gels containing 0.5 µg/ml of ethidium bromide. 
For all polymorphisms, repeated genotyping analyses 
were randomly performed in 10% of the samples.
-Statistical Analyses
The distribution of the genotypes was evaluated by 
Hardy-Weinberg equilibrium test, and the frequency 
distribution of alleles and genotypes under unrestricted 
and dominant genetic models was compared using cross-
tabulation and standard chi-square test. In unrestricted 
analysis, it was assumed that all 3 genotypes have differ-
ent disease odds, whereas in dominant model the hetero-
zygote and rare homozygote have the same disease odds. 
To estimate the risk of each factor in the occurrence of 
NSCL/P, odds ratios (OR) and respective 95% confidence 
intervals (95% CI) were calculated. Multiple compari-
sons were corrected using the Bonferroni method. The 
Med Oral Patol Oral Cir Bucal. 2013 May 1;18 (3):e414-20.                                                                                                                           Genetic variants in nonsyndromic cleft lip and/or palate
e416
assessment of gene-gene interactions was carried out us-
ing multifactor dimensionality reduction (MDR), which 
identifies combinations of genotypes associated with risk 
for the disease. In this study, we used 10-fold cross vali-
dation and 1000-fold permutation testing.
Results
From 13 polymorphisms, only 4 of them, includ-
ing rs28649236 and rs4819522 of TBX1, rs7940667 of 
PVRL1 and rs1057744 of JAG2, demonstrated genotypic 
variations in our population. The genotype distributions 
were consistent with Hardy-Weinberg equilibrium at all 
loci except for rs28649236 in TBX1.
Allelic and genotypic frequencies are depicted in tables 1,2. 
The percentage of the variant allele of TBX1 rs28649236 
polymorphism was significantly lower in NSCL/P patients 
than that in controls (p=0.0002), with an odds ratio of 0.41 
(95% CI: 0.25-0.67) (Table 1). The frequency of the rare 
genotypes AG and GG were significantly higher in con-
trol group compared to NSCL/P group (p=0.01), but this 
significance did not remained after Bonferroni correction 
for multiple comparisons (Table 2). However, when AG 
and GG were combined and compared against AA geno-
type (dominant genetic model), a significant association 
was observed. The AG/GG genotype was significantly 
more frequent in the control group (10.4%, n=43) than in 
the NSCL/P group (4.9%, n=18) (p=0.004), revealing an 
association with NSCL/P (OR: 0.44, 95% IC: 0.25-0.78). 
The frequency of TBX1 rs4819522 genotypes in a domi-
nant genetic model (CC vs CT+TT) was different between 
groups, but this difference was not kept after Bonferroni 
correction (Table 2). Similarly, PVRL1 rs7940667 CC 
genotype was more frequent in the control group com-
pared with NSCL/P group, but this difference did not resist 
Bonferroni adjustment (Table 2). The frequency of the GA 
genotype for rs1057744 JAG2 polymorphism was higher 
than GG and AA genotypes, but no significant differences 
between groups were observed (Table 2). There were no 
significant associations, after Bonferroni adjustment, be-
tween polymorphisms and cleft types (Table 3). However, 
our data indicated a marginal significance between TBX1 
polymorphisms and CLP and between PVRL1 rs7940667 
polymorphism and CPO.
Potential interactions among the genes were assessed us-
ing MDR analysis (Table 4). The combination of TBX1 
rs28649236 and PVRL1 rs7940667 was the best two 
factor model with a testing accuracy of 0.52. The best 
three factor combination, TBX1 rs28649236, PVRL1 
rs7940667 and TBX1 rs4819522, demonstrated the ac-
curacy of 0.59 and the cross validation consistency of 
7/10. However, no model was significant in predicting 
the individual risk for NSCL/P.
Polymorphism Control Group
(n=413)
NSCL/P Group
(n=367)
OR (95% IC) p value
n % n %
TBX1
rs28649236
Allele A 764 92.5 710 96.7 Reference
Allele G* 62 7.5 24 3.3 0.41 (0.25-0.67) 0.0002
rs4819522
Allele C 641 77.6 544 74.1 Reference
Allele T* 185 22.4 190 25.9 1.21 (0.96-1.53) 0.10
PVRL1
rs7940667
Allele C 713 86.3 627 85.4 Reference
Allele A* 113 13.7 107 14.6 1.07 (0.81-1.43) 0.61
JAG2
rs1057744
Allele A 487 58.9 416 56.7 Reference
Allele G* 339 41.1 318 43.5 1.09 (0.89-1.34) 0.36
Table 1. Allelic frequencies of TBX1, PVRL1 and JAG2 polymorphisms in the control and NSCL/P groups. Major alleles were used as reference 
for comparisons.
*Minor alleles.
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Polymorphism Control Group
(n=413)
NSCL/P Group
(n=367)
OR (95% IC) p value
n % n %
TBX1
rs28649236
AA 370 89.6 349 95.1 Reference
AG 24 5.8 12 3.3 0.53 (0.26-1.07) 0.01
GG 19 4.6 6 1.6 0.33 (0.13-0.84)
AG+GG 43 10.4 18 4.9 0.44 (0.25-0.78) 0.004
rs4819522
CC 251 60.7 196 53.4 Reference
CT 139 33.7 152 41.4 1.40 (1.04-1.88) 0.08
TT 23 5.6 19 5.2 1.06 (0.56-1.99) 0.03
CT+TT 162 39.3 171 46.6 1.35 (1.02-1.79)
PVRL1
rs7940667
CC 311 75.3 263 71.7 Reference
CA 91 22.0 101 27.5 1.31 (0.95-1.82) 0.04
AA 11 2.7 3 0.8 0.32 (0.09-1.17)
CA+AA 102 24.7 104 28.3 1.21 (0.88-1.66) 0.25
JAG2
rs1057744
AA 148 35.8 117 31.8 Reference
AG 191 46.2 182 49.5 1.20 (0.87-1.65) 0.49
GG 74 17.9 68 18.5 1.16 (0.77-1.75)
AG+GG 265 64.1 250 68.1 1.19 (0.88-1.61) 0.24
Table 2. Genotype distributions under unrestricted and dominant genetic model of TBX1, PVRL1 and JAG2 polymorphisms in the control and 
NSCL/P groups.
Discussion
Several evidences indicate that NSCL/P, as resulted of 
genetic heterogeneity, low penetrance and influence 
of a variety of environmental factors, is a genetically 
complex disease (1,2). Although there has been marked 
progress in identifying genetic and environmental trig-
gers for NSCL/P, the etiology remains poorly charac-
terized. In this study we evaluated 13 polymorphisms 
in 9 genes in patients with NSCL/P, and found that the 
G allele of TBX1 rs28649236 polymorphism was sig-
nificantly associated with occurrence of NSCL/P, even 
after correction for multiple comparisons.
The rs28649236 nonsynonymous polymorphism in 
TBX1 replaces an arginine by a glycine at amino acid po-
sition 8 (p.Arg8Gly) of the protein sequence. Although 
there is no information of effect of this polymorphism 
on protein function, by using bioinformatic analysis (18) 
we observed that the polymorphic nucleotide is located 
in a putative area used for alternative splicing and the 
substitution may result in an alteration on the encoded 
protein, suggesting biological effects. The G variant al-
lele was significantly more frequent in the control group 
than in the NSCL/P group, and an individual carrying 
the G allele exhibited a ~2.5-fold lower risk to having 
NSCL/P. However, the distribution of alleles and geno-
types showed no association with the type of cleft. A 
statistical significance of the rs28649236 deviation from 
Hardy-Weinberg equilibrium was observed. This distor-
tion may be due to genotyping errors or random chance, 
since 1 in every 20 markers can present imbalance (19). 
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?
Polymorphism Control 
n (%) 
CLO
n (%) 
OR (95% IC) / p 
value
CLP
n (%) 
OR (95% IC) / p 
value
CPO
n (%) 
OR (95% IC) / p 
value
TBX1        
rs28649236        
AA 370 (89.6) 84 (95.4) Reference 188 (94.9) Reference 77 (95.0) Reference 
AG 24 (5.8) 3 (3.4) 0.55 (0.16-1.87) / 0.33 6 (3.1) 0.49 (0.19-1,22) / 0.12 3 (3.7) 0.6 (1.17-2.04) / 0.41 
GG 19 (4.6) 1 (1.2) 0.23 (0.03-1.75) / 0.12 4 (2.0) 0.41 (0.14-1.23) / 0.10 1 (1.3) 0.25 (0.03-1.91) / 0.15 
AG+GG 43 (10.4) 4 (4.6) 0.41 (0.14-1.17) / 0.08 10 (5.1) 0.45 (0.22-0.93) / 0.02 4 (5.0) 0.44 (1.15-1.28) / 0.12 
rs4819522        
CC 251 (60.7) 52 (59.1) Reference 103 (52.0) Reference 41 (50.6) Reference 
CT 139 (33.7) 33 (37.5) 1.14 (0.71-1.85) / 0.58 83 (41.9) 1.45 (1.02-2.07) / 0.03 36 (44.4) 1.58 (0.96-2.59) / 0.06 
TT 23 (5.6) 3 (3.4) 0.63 (1.18-2.17) / 0.46 12 (6.1) 1.27 (0.61-2.65) / 0.52 4 (5.0) 1.06 (0.35-3.23) / 0.91 
CT+TT 162 (39.3) 36 (40.9) 1.07 (0.67-1.71) / 0.77 95 (48.0) 1.43 (1.01-2.01) / 0.04 40 (49.4) 1.51 (0.93-2.43) / 0.09 
PVRL1        
rs7940667        
CC 311 (75.3) 63 (71.6) Reference 148 (74.7) Reference 52 (64.2) Reference 
CA 91 (22.0) 25 (28.4) 1.35 (0.81-2.27) / 0.24 49 (24.7) 1.13 (0.76-1.68) / 0.54 27 (33.3) 1.77 (1.05-2.98) / 0.03 
AA 11 (2.7) 0 NA 1 (0.6) 0.19 (0.02-1.49) / 0.08 2 (2.5) 1.08 (0.23-5.07) / 0.91 
CA+AA 102 (24.7) 25 (28.4) 1.21 (0.72-2.02) / 0.46 50 (25.3) 1.03 (0.69-1.52) / 0.88 29 (35.8) 1.70 (1.02-2.82) / 0.03 
JAG2        
rs1057744        
AA 148 (35.9) 28 (31.8) Reference 58 (29.3) Reference 31 (38.3) Reference 
AG 191 (46.2) 42 (47.7) 1.16 (0.68-1.96) / 0.57 103 (52.0) 1.37 (0.93-2.02) / 0.10 37 (45.7) 0.92 (0.54-1.56) / 0.77 
GG 74 (17.9) 18 (20.5) 1.28 (0.66-2.47) / 0.45 37 (18.7) 1.27 (0.77-2.09) / 0.33 13 (16.0) 0.84 (0.41-1.70) / 0.62 
AG+GG 265 (64.1) 60 (68.2) 1.19 (0.73-1.96) / 0.47 140 (70.7) 1.35 (0.93-1.94) / 0.11 50 (61.7) 0.90 (0.55-1.47) / 0.67 
Table 3. Genotype distributions of TBX1, PVRL1 and JAG2 polymorphisms by type of cleft. Control group was used for comparison.
CLO: cleft lip only, CLP: cleft lip and palate, CPO: cleft palate only, NA: not applicable.
Although we have repeated genotyping analysis in 
more than 10% of the samples for quality control and 
the results were totally concordant, the possibilities of 
PCR genotyping errors because of nucleotide sequence 
mutations, unreported polymorphisms and INDELS at 
the PCR primer sites exist. In addition, previous studies 
with the Brazilian population also found Hardy-Wein-
berg imbalance, which was credited to the ethnic com-
plexity of our population (20,21). Brazilians form one of 
the most heterogeneous populations in the world, which 
is the result of five centuries of interethnic crosses of 
peoples from three continents: the European coloniz-
ers, mainly represented by the Portuguese, the African 
slaves, and the Amerindians (22). Thus, the signifi-
cance of the G allele of rs28649236 in TBX1 might be 
related to higher European contribution present in our 
sample. To date, there is no previous studies evaluating 
this polymorphism in NSCL/P. Han and colleagues (23) 
demonstrated an increased frequency of the G allele in 
children with conotruncal defects. TBX1 mRNA ex-
pression was described to be essential to coronary tissue 
development during embryogenesis (24), supporting the 
association of rs28649236 with heart defects. Interest-
ingly, TBX1 was recently associated with the elongation 
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Number of 
factors
Best model Testing accuracy CVCa OR (95% IC) Permutation test
p valueb
2
TBX1 rs28649236
PVRL1 rs7940667 0.52 10/10 1.68 (0.68-4.12) 0.14
3
TBX1 rs28649236
PVRL1 rs7940667
TBX1 rs4819522
0.59 7/10 1.78 (0.72-4.37) 0.24
4
TBX1 rs28649236
PVRL1 rs7940667
TBX1 rs4819522
JAG2 rs1057744
0.57 10/10 1.82 (0.72-3.56) 0.12
Table 4. Interactions between TBX1, PVRL1 and JAG2 and risk prediction of NSCL/P by multifactor dimensionality reduction method.
aCVC: cross validation consistency. bp value based on 1.000 permutations.
and elevation of the palatal shelves during palatogenesis 
(25). Thus, this significant result provides evidence of 
a new susceptibility marker for NSCL/P, and supports 
future studies involving larger groups of patients and 
other ethnic populations.
Borderline associations with NSCL/P were found with 
other two markers of this study. We have found that CT 
and TT individuals for TBX1 rs4819522 polymorphism 
have an increased risk of NSCL/P in our population. 
However, this association did not resist the adjustment 
for multiple comparisons of Bonferroni. One of the 
main issues in association studies is how to evaluate 
the significance of multiple testing of polymorphims. 
Bonferroni correction is commonly applied, but it is too 
stringent, whereas an alternative approach would be to 
use replication of a nominal probability in a second data 
set, which is less rigid. Since we did not have access to 
a second dataset, we applied the Bonferroni correction. 
As significant associations for this study required an 
adjusted p≤0.004, the significance of TBX1 rs4819522 
polymorphism was lost. We realize that this correc-
tion is a limitation and may lead to loss of significant 
findings, but in light of not having verification, this ap-
proach appeared to be the most efficacious. No previous 
studies assessed the correlation of this polymorphism 
with NSCL/P. Because of the marginal association, this 
candidate marker requires replication in other sample 
sets, and also should impel others to investigate such 
association in different populations.
The first evidence in favor of a role for PVRL1 variants 
in NSCL/P was obtained by Sözen and collaborators 
(26). Those authors demonstrated a strong association 
between PVRL1 W185X mutation and NSCL/P in indi-
viduals from Venezuela. The same group demonstrated 
Pvrl1 mRNA expression in the medial edge epithelium 
of the palatal shelves (5). Allelic and genotypic associa-
tion studies of PVRL1 polymorphisms and mutations in 
NSCL/P patients have yielded inconsistent results, but 
overall do support the association of PVRL1 defects 
with risk of NSCL/P (12-14,27,28). In particular, PVRL1 
rs7940667 polymorphism was significantly associated 
with the development of NSCL/P, especially in the iso-
lated forms of CL and CP, in populations from Iowa-
USA, Philippines and Denmark (12). Recently, a lack 
of association between rs7940667 polymorphism and 
North American Caucasian, Australian and Guatemalan 
NSCL/P patients was reported (13,14). JAG2 encodes a 
ligand for Notch pathway receptors and is required for 
craniofacial, limb and T cell development (29). The first 
evidence showing that JAG2 may be related to oral clef-
ting came from animal studies, where Jag2 knockout 
mice die at birth due to completely penetrant cleft palate 
(11). Later, several studies have evaluated the participa-
tion of JAG2 genetic variants in NSCL/P, but the results 
are inconsistent (13,15,30). As in the present study, a lack 
of association between rs1057744 polymorphism and 
NSCL/P was reported in single polymorphism analysis 
(18). However, a strongest association was observed in 
haplotype analyses containing this polymorphism (18). 
Therefore, further studies are required to explore the 
precise contribution of JAG2 variants and/or haplotypes 
in NSCL/P in the Brazilian population.
On examining epistatic interactions, our results showed 
no significant correlation between the combinations and 
the risk for NSCL/P. Thus, rs28649236 of TBX1 gene 
appears to contribute independently to a decreased 
NSCL/P risk. Finally, nine of the probably polymor-
phisms of the selected candidate genes were not con-
firmed in the Brazilian population. These results are not 
surprising since two of them (TP63 rs34713855, RUNX2 
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rs11498200, TGFβ3 rs4252315, MSX1 rs62636562) 
are invariable in practically all populations studied 
(GenBank, http://www, ncbi.nlm.nih.gov), and the 
others (MID1 rs55986608, TBX1 rs28939675, MYH9 
rs11549909 and rs11549910, TGFβ3 rs34019007) have 
never been studied before. 
In conclusion, this study suggests an association be-
tween the G allele of TBX1 rs28649236 polymorphism 
and the development of NSCL/P in the Brazilian popu-
lation, while that the associations of TBX1 rs4819522, 
PVRL1 rs7940667 and JAG2 rs1057744 with NSCL/P 
require further studies.
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